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Voiding Dysfunction
Readjustable Sling Procedure for the Treatment of Female Stress 
Urinary Incontinence with Intrinsic Sphincter Deficiency: 
Preliminary Report
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Purpose: The Remeex (Mechanical External Regulation) sling is a mid-urethral sling 
that allows adjustment of the sling tension in the postoperative period. We evaluated 
the early outcomes of the procedure in patients in whom the success rate of tension-free 
slings is low, such as with intrinsic sphincter deficiency (ISD).
Materials and Methods: We included 17 women with urodynamically proven stress uri-
nary incontinence (SUI) who underwent the Remeex procedure and were followed for 
at least 12 months. The patients were considered to have ISD on the basis of a Valsalva 
leak point pressure (VLPP) ＜60 cmH2O or a maximum urethral closure pressure 
(MUCP) ＜20 cmH2O. We analyzed parameters including history taking, urodynamic 
study (UDS), and postoperative clinical outcomes. Patient’s success and satisfaction 
rates were evaluated after the procedure. Also, we asked about lower urinary tract 
symptoms (LUTSs) with a questionnaire, and the severity of LUTSs was assessed with 
the Visual Analog Scale (VAS) before and 12 months after the operation. 
Results: The patients’ mean age was 55.6±9.58 years. Four (23.5%) patients had mixed 
incontinence. Five patients (29.4%) had undergone previous surgery for SUI. At a mean 
follow-up of 13.3 months (range, 12-16 months), 14 patients (82.3%) were cured and 
3 patients (17.6%) were improved. Four patients (23.5%) answered very satisfied and 
13 patients (76.4%) answered satisfied on the satisfaction questionnaire. Also, LUTSs 
were improved except voiding pain (p＜0.05).
Conclusions: This procedure provides high cure and satisfaction rates. Our results dem-
onstrate that the Remeex procedure is suitable for women with SUI with ISD. 
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INTRODUCTION
Urinary incontinence is generally defined as the in-
voluntary loss of urine. It produces serious economic, so-
cial, and psychological problems that have a significant im-
pact on women's health. Stress urinary incontinence (SUI) 
is involuntary leakage of urine during effort, exertion, 
sneezing, or coughing [1]. According to its mechanism, SUI 
is categorized into anatomical urinary incontinence due to 
urethral hypermobility and intrinsic sphincter deficiency 
(ISD) [2]. A variety of surgical techniques have been devel-
oped on the basis of research on SUI, and tension-free vagi-
nal tape (TVT), which was introduced in 1996, has been fre-
quently used. The success rates of the TVT procedure have 
been reported to be above 80-100% [3-6]. Many factors can 
produce the recurrence of SUI after surgery, however, such 
as the presence of a hidden ISD, mixed incontinence, hor-
monal changes, age-related collagen alteration, and sig-
nificant weight gain. Success rates of the tension-free sling 
in SUI with ISD are 24-84%, although it was differently re-
ported according to research in comparison with the suc-
cess of anatomical urinary incontinence to treat urinary in-Korean J Urol 2010;51:420-425
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continence [7-9]. The most common problem of sling sur-
gery has been excess tension, and concern over post-
operative bladder outlet obstruction has led to the develop-
ment of a number of methods for determining the proper 
tension. Remeex is a re-adjustable sling system for the sur-
gical treatment of female SUI. This procedure permits the 
adjustment and readjustment of sling tension intra-oper-
atively or during the postoperative period with minimally 
invasive ambulatory surgery, which can be performed un-
der local anesthesia months or even years after the first 
procedure. Therefore, it has the advantages that urinary 
retention can be obtained and incontinence can be 
minimized. In the present study, we analyzed the results 
of Remeex surgery in Korean women with SUI to determine 
whether it is effective for SUI with ISD. 
MATERIALS AND METHODS
1. Patient group 
Seventeen patients were diagnosed with SUI with ISD by 
urodynamic study (UDS) at the urology department and 
underwent the Reemex procedure from February 2007 to 
March 2009 and were followed up for more than 12 months. 
All patients were preoperatively evaluated through his-
tory taking, physical examination, symptom ques-
tionnaire, 1-hour pad test, and UDS. Patients with neuro-
logical disorders or detrusor overactivity were excluded 
from this protocol. Additional minor exclusion factors in-
cluded chronic degenerative diseases that would affect 
muscular and nerve tissues, advanced genital prolapses, 
and active or recurrent urinary tract infections. Subjects 
were required to have a positive result on a cough stress 
test and ＞10 g of leakage as measured by a 1-hour pad test 
with a standardized bladder volume (200 ml) [10]. A urody-
namic evaluation was also performed. Methods, defi-
nitions, and units conformed to standards proposed by the 
International Continence Society [11]. Subjects were con-
sidered to have ISD identified by the Valsalva leak point 
pressure (VLPP) ＜60 cmH2O measurement in the sitting 
position with a volume of 150 ml in the bladder or by the 
maximum urethral closure pressure (MUCP) ＜20 cmH2O 
measurement in the sitting position with a volume of 200 
ml in the bladder. 
　The operation was carried out under spinal anesthesia. 
Operation time, hospitalized time, complications, objective 
success, and satisfaction rate and change in lower urinary 
tract symptoms (LUTSs) were evaluated. Objective out-
comes were assessed by clinical examination and a 1-hour 
pad test. The outcome measurement was the objective cure 
of stress incontinence based on a negative pad test with a 
standardized bladder volume (＜2 g in weight) [10]. When 
the patients had insignificant incontinence after surgery 
(＜10 g in weight), they were defined as improved. When 
the degree of incontinence did not change after surgery (＞
10 g in weight), it was defined as a failure. Success rates 
included cure and improvement. Patients' subjective satis-
faction was investigated by using a questionnaire which 
asked them to classify their level of satisfaction with the 
outcome of the surgery by selecting one of four grades (very 
satisfactory, satisfactory, usual, and unsatisfactory). The 
LUTSs evaluated included frequency, nocturia, urgency, 
urge incontinence, residual urine sensation, and dysuria. 
To quantify overall satisfaction in urination before and af-
ter surgery with respect to each LUTS, a VAS was used to 
compare changes in VAS points before and after surgery. 
The VAS ranged from 0 for very satisfactory to 10 for very 
unsatisfactory. 
　All patients were evaluated at 1, 2, and more than 12 
months. We conducted Student's t-tests, one-way ANOVA, 
and chi-square tests on the results of the study with the use 
of SPSS 10.0. When groups were compared and the p-value 
was below 0.05, it was judged as significant. 
2. Operation technique 
The Remeex system consists of a regulation device 
(varitensor) and a short polypropylene sling (35x12 mm) 
with suspension suture threads. The Remeex mechanical 
regulation part is a subcutaneous permanent implant with 
the “varitensor,” which permits adjustment of the sling 
support from outside the body by means of an external ma-
nipulator (EM). The varitensor also has a mechanical con-
necting point for the EM on its upper side. These compo-
nents are made of biocompatible materials such as tita-
nium and ultra-high-molecular-weight polyethylene 
(Chirulen
Ⓡ). First, we made a 3 cm abdominal incision just 
over the pubis. The sling was placed at the level of the 
mid-urethra through a vaginal incision, and the suspen-
sion threads were passed through the Retzius space by a 
suture passer needle driven by a passer handle. After we 
checked the bladder integrity, the suspension threads were 
introduced into the varitensor. The tension of the sling 
could then be regulated. Clockwise rotation elevates the 
sling, and counterclockwise rotation lowers the sling. The 
adjustment can be made in the operating room according 
to surgical experience. The following morning the catheter 
was removed, and after filling the bladder with 300 ml of 
saline, we controlled the incontinence level, with the pa-
tient standing up and doing incontinence maneuvers, and 
regulated the sling elevation accordingly. Then we asked 
the patient to urinate and we measured the residual urine. 
The EM is a disposable part of the set that is removed once 
the desired continence level is achieved. If this was ＞100 
ml, we lowered the sling tension. When there was no incon-
tinence and the residual was ＜100 ml, we disconnected the 
manipulator and discharged the patient. 
RESULTS
The mean age of the study subjects was 55.66±9.58 years. 
The numbers of patients who underwent hysterectomy and 
incontinence TVT operations were four and five, respec-
tively. Four of the 17 patients had mixed incontinence. All 
of the patients were postmenopausal, their mean parity 
was 2.7±1.4, and the mean observation period was 13.3 Korean J Urol 2010;51:420-425
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TABLE 1. Characteristics of the patients and urodynamic para-
meters
Characteristics n=17
Mean age (years)
Mean parity (times)
Menopausal women (%)
No. of previous hysterectomy (%)
No. of previous incontinence repair (%)
Mixed incontinence (%)
Mean follow up (months)
1 hour pad test (g)
Preoperative urodynamic parameters
　Qmax (ml/s)
　Voided volume (ml)
　PVR (ml)
　VLPP (cmH2O)
　MUCP (cmH2O)
55.66±9.58
2.7±1.4
17 (100)
4 (23.5)
5 (29.4)
4 (23.5)
13.3 (12-16)
55 (23-154)
35.9±11.5
316.4±97.8
12±12.5
53.2±18.4
29.8±11.6
Qmax: maximal flow rate, PVR: post void residual, VLPP: Valsalva
leak point pressure, MUCP: maximal urethral closure pressure
TABLE 2. The operative data
Postoperative results n=17
Operation time (minutes)
Hemoglobin change (g/dl)
Hospital stay (days)
Mean duration of the postoperative urethral
 catheterization (days)
No. of tape-tension-regulated patients after
 operation (n)
Short-term complication (1-2 months)
　Bladder perforation (%)
　Intestine perforation (%)
　Wound infection (%)
　Bleeding (%) 
　Difficult emptying (%)
　De novo urgency (transient) (%)
Long-term complication (12-16 months)
　Urinary obstruction (%)
　Chronic pain (%)
　Mesh erosion (%)
　Dyspareunia (%)
　Weak stream (%)
　De novo urgency (%) 
32 (25-45)
0.65 (0-1.5)
3.1 (2-5)
2.6 (2-4)
8
0 (0)
0 (0)
1 (5.8)
0 (0)
3 (17.6)
4 (23.5)
0 (0)
1 (5.8)
0 (0)
0 (0)
0 (0)
0 (0)
TABLE 3. Objective cure rate and subjective satisfaction with the
surgical procedure after 12 months
n=17
Objective cure rate
    Cure (%)
    Improve (%)
    Fail (%)
    Success rate (%)
Subjective satisfaction rate
    Very satisfied (%)
    Satisfied (%)
    Usual (%)
    Unsatisfactory (%)
14 (82.3)
  3 (17.6)
  0 (0)
17 (100)
  4 (23.5)
13 (76.4)
  0 (0)
  0 (0)
Success rate: cure＋improvement
TABLE 4. Changes in the VAS after 12 months
Group Pre procedure Post procedure
Frequency
Nocturia
Urgency
Urge incontinence
RU sensation
Dysuria
5.2
5.5
4.1
3.0
5.4
2.9
1.9
a
1.8
a
2.5
a
1.7
a
2.9
a
3.4
VAS: visual analogue scale, RU: residual urine, 
a: p＜0.05
months. The mean preoperative 1-hour pad test was 55 g 
(Table 1). There were no intraoperative complications, the 
mean operation time was 32 minutes (range, 25-45 mi-
nutes), and the mean duration of postoperative urethral 
catheterization was 2.6 days (range, 2-4 days). No patient 
needed catheterization for more than 4 days. Immediate 
postoperative regulation (the day after surgery) was neces-
sary in 8 of the 17 patients. They showed no significant com-
plications such as damage to the urinary bladder, the intes-
tines, and blood vessels or hematoma. However, they had 
the following short-term complications: four patients 
(23.5%) had transient urgency, one patient (5.8%) had 
wound infection, and three patients (17.6%) had difficulty 
emptying. All of them improved after manipulator control. 
The following long-term complications occurred: one pa-
tient (5.8%) had suprapubic wound pain and three patients 
with hyperactivity de novo required anticholinergic trea-
tment. No other complications were found (Table 2). Post-
operatively, in 5 of the 17 patients, the stress test with 300 
ml volume in the bladder was positive after catheter re-
moval and we needed to increase the sling tension by rota-
ting the manipulator of the varitensor clockwise a mean of 
5 mm. In 3 of the 17 patients the residual was abnormal, 
and we had to decrease the sling tension by rotating the ma-
nipulator counterclockwise by a mean of 4 mm. Urgency 
was present in four patients while we regulated the pros-
thesis, which made the procedure of precise adjustment of 
the sling tension difficult. Three of these patients had 
mixed incontinence and were treated with anticholinergics. 
One month and 2 months after surgery, three patients still 
complained of stress incontinence that was confirmed by 
a stress test and a positive pad test. We therefore modified 
the sling support level at 2 months postoperatively. At 12 
months, postoperative symptoms of incontinence were 
cured in 14 patients and improved in 3 patients. No failures 
occurred and the success rate (cure＋improvement) was 
100%. Four patients (23.5%) answered that they were very 
satisfied and 13 patients (76.4%) answered that they were 
satisfied. All patients answered that they were 100% sat-
isfied (Table 3). In the VAS point change in LUTSs after 
surgery showed significant improvement in frequency, 
nocturia, urgency, urge incontinence and residual urine Korean J Urol 2010;51:420-425
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sensation. However, dysuria was somewhat worsened 
(Table 4).
DISCUSSION 
Urine leakage occurs when the bladder neck opens as ab-
dominal pressure increases without contraction of the de-
trusor muscle. Its causes are categorized into urethral hy-
permobility and ISD [2]. In 1996, Ulsten et al introduced 
TVT, which is a variant of sling surgery. It has been ex-
tensively used for the treatment of SUI [11]. The short- 
term results of TVT currently reported are 80-100% sat-
isfactory [3,12,13]. Nilsson et al observed 80 patients for 
7 years and reported an 81.3% success rate [14]. However, 
according to a report by Mazouni, 60% had voiding diffi-
culty after TVT surgery [15], and severe complications such 
as misplacement of the tape in the bladder or urethra due 
to bladder perforation or urethral erosion, vessel injury, 
and bowel perforation have been reported [16]. In 2001, 
Delorme suggested using the mid-urethra sling with the 
polypropylene mesh passing through the obturator fora-
men instead of the Retzius space. Liapis et al reported that 
the full recovery rates of the Monarc and TVT-O procedures 
were 90% and 87% after 1 year of follow-up observation 
[17]. In a study by Seok et al, 14% of patients complained 
of mild voiding difficulty after TOT surgery, but it was low-
er than in those who had TVT [18]. 
　ISD means insufficiency of the urethral sphincter re-
gardless of anatomical locations, which was suggested by 
McGuire [19]. Some controversy exists over the definition 
of ISD. To diagnose ISD, we usually measure VLPP and 
MUCP. When the urinary bladder is filled with 150-200 ml 
and VLPP is below 60 cmH2O or MUCP is below 20 cmH2O, 
ISD is determined [20]. Kim et al categorized patients who 
had TVT into a group with VLPP above 60 cmH2O and a 
group with VLPP below 60 cmH2O and evaluated them for 
5 years. Because they found no significant difference in the 
success rates between the two groups, Kim et al reported 
that VLPP is not a factor that affects the success of TVT [21]. 
But Paick et al categorized 221 patients who had TVT into 
a group whose VLPP was above 60 cmH2O and a group 
whose VLPP was below 60 cmH2O and observed them for 
a mean period of 10.5 months. Success rates were 93.1% 
and 82%, and the group with lower VLPP showed lower suc-
cess rates of TVT [7]. Rezapour et al determined the follow-
ing cases as high-risk factors of failure: when patients are 
older than 70 years, when MUCP is below 10, and when the 
patients have an immotile urethra. After TVT surgery for 
SUI with ISD, 74% (36 of 49 patients) showed success and 
12% (12) improved. The success rate was 86%, which was 
lower in comparison with TVT for patients with anatomical 
urinary incontinence [22]. In 2006, Doo et al conducted TVT 
targeting 31 patients with VLPP below 60 cmH2O and 64 
with VLPP above 60 cmH2O. Five years later, full recovery 
rates were 51.6% and 82.8%, respectively. The success rate 
of the ISD group was significantly lower [23]. When MUCP 
was below 20 cmH2O, the success rate of TVT was 73% [24]. 
　Recently, TOT has been used for the treatment of SUI 
patients along with TVT, but there have been only a few 
reports on its outcomes for SUI with ISD. O'Connor et al 
categorized 43 patients who had TOT into a group with 
VLPP above 60 cmH2O and a group with VLPP below 60 
cmH2O and observed them for 6 months. They reported 
that the full recovery rate of the former group was 25%, 
which was significantly lower than that of the latter group 
of 77%. The difference was because the mesh tape of TOT, 
which was more horizontally placed, lacked support be-
cause it wrapped a smaller part of the urethra in compar-
ison with that by TVT [9]. Surgical procedures to treat SUI 
generally aim at lifting and supporting the urethrovesical 
junction. Sub-urethral slings serve this purpose well. The 
overall goal of the sling operation is to produce adequate 
urethral resistance to prevent stress incontinence, allow-
ing voluntary and complete bladder emptying. Slings that 
are too tight are associated with voiding dysfunction and 
de novo urge incontinence. Slings that are too loose may 
still allow stress incontinence. 
　The most common problem with sling surgery has been 
the excess tension of the sling and concern over post-
operative bladder outlet obstruction, which has led to the 
development of a number of methods for determining prop-
er sling tension. If SUI reappears or the patient suffers per-
sistence of urinary leakage after surgery, it will lead us to 
perform a new intervention to correct it. However, the suc-
cess rate of incontinence reoperations is between 20% and 
40% lower than that of first-time operations, and these pro-
cedures present a greater number of complications. The 
sub-urethral sling has traditionally been considered a pro-
cedure of last resort for previous surgical failures and for 
those patients with severe ISD [25]. 
　The Remeex system allows postoperative adjustment of 
the sling tension. This sling system allows the surgeon to 
leave the sling very loose at the time of surgery with the 
ability to tighten or loosen the sling easily in the post-
operative period to achieve continence and still maintain 
adequate voiding function. This system is composed of a 
sub-urethral sling with two traction thread sutures con-
nected to a regulation device (varitensor) positioned above 
the fascia of the abdominal muscle. The varitensor and the 
sling remain implanted to allow readjustment of the blad-
der suspension level. The ability to readjust the tension 
avoids postsurgical urinary retention and ensures long- 
term continence. 
　Early reports from the literature [26] on the Remeex pro-
cedure showed a subjective success rate of 90%. The most 
common postoperative complication is de novo overactive 
bladder (4.7-12.5%); wound infections (3.5%) and vaginal 
erosion (0.8%) are also reported. Mantovani et al conducted 
Remeex on 32 women with SUI who had a fixed urethra, 
urethral hypermobility, ISD, or failed in previous surgery 
and observed them for 3 years. They reported that 31 were 
fully recovered except for one patient who had the instru-
ment removed because of infection [27]. Araco et al con-
ducted surgery on 38 patients with ISD and controlled the Korean J Urol 2010;51:420-425
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tension of 3 patients (7.9%) 6 months after the surgery. It 
was reported all of them showed successful results 1 year 
after the surgery [28]. Moreno et al evaluated the results 
of the Reemex system in 683 Spanish patients. They re-
ported that the mean patient age was 59.9 years (range, 
21-87 years) with a mean follow-up of 23 months (range, 
6-93 months). In the total group, 30.2% of the patients had 
mixed incontinence, 73.1% of the patients had ISD, 35.7% 
of the patients had a previous history of failed surgical in-
terventions for urinary incontinence, and 54.3% of the pa-
tients had previous pelvic-floor-associated operations. The 
cure rate was 92.2%, with 6.9% improvement and only 0.9% 
failures. No patients suffered voiding difficulties in the 
long term [29]. 
　In 2010, Errando et al evaluated the outcomes, complica-
tions, and quality of life of patients after a Remeex system 
for recurrent SUI and ISD indications [30]. One hundred 
twenty-five patients with SUI were prospectively evaluated. 
They reported that after a mean follow-up of 38 months 
(range, 26-72 months), 109 patients (87%) were cured of 
SUI on the basis of a pad-test and clinical, and 16 patients 
(13%) remained incontinent. But, 9 of those (7%) were sat-
isfied to the point that they declined re-adjustment of the 
sling, and 7 (6%) are on the waiting list for re-adjustment. 
The varitensor was removed in 1 case because of infection. 
No other complications were seen [30]. Our results are also 
similar with literature reviews [26-30] of the Remeex sys-
tem in women with SUI. Therefore, it is suggested that the 
Remeex system is a minimally invasive technique with 
good, consistent results in groups of Korean female SUI pa-
tients with ISD.
CONCLUSIONS
We provided the Remeex adjustable sling system to 17 
Korean women with SUI and evaluated the early outcomes 
of the Remeex procedures. The procedure provides good 
cure and satisfaction rates for female SUI caused by ISD 
with a low complication rate. The only specific difficulties 
or complications are related to the varitensor, which should 
be removed in case of chronic pain or infection. For this rea-
son, we consider the Remeex system in patients in which 
the success rate of tension-free slings is lower. This study 
targeted a small number of subjects and the follow-up period 
was short. This study suggests that more subjects and a longer 
follow-up period are needed for more specific evaluation. 
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